Additionally, I only needed radiation, not chemotherapy
In the next year, we will have the study to show whether it makes sense to give finerenone to protect the kidney in people with type 1 diabetes and CKD. Other trials of note include Remodel T1D and SUGARNSALT, but neither is sponsored by a drug company
A comprehensive safety review confirmed the association between MT-II and atypical nevi changes (PubMed 25929579)
The post hoc analysis found that tirzepatide at all doses investigated reduced the prevalence of metabolic syndrome related to cardiovascular risk factors more than placebo, semaglutide 1 mg, insulin degludec, and insulin glargine [117]
Rapid fat loss
[2] Rosenstock, J., Frias, J., Jastreboff, A